LQDA Return on Tangible Equity | LIQUIDIA CORPORATION

LIQUIDIA CORPORATION (LQDA) Return on Tangible Equity

2026-06-30: Return Tang Equity 72.49%.
2026-03-31: Return Tang Equity 21.31%.
2025-12-31: Return Tang Equity -168.75%.
2025-09-30: Return Tang Equity -672.15%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	72.49%
2026-03-31	21.31%
2025-12-31	-168.75%
2025-09-30	-672.15%
2025-06-30	-1324.53%
2025-03-31	-298.13%
2024-12-31	-169.98%
2024-09-30	-107.69%
2024-06-30	-147.95%
2024-03-31	-103.90%
2023-12-31	-180.92%
2023-09-30	-130.57%
2023-06-30	-89.66%
2023-03-31	-47.36%
2022-12-31	-47.41%
2022-09-30	-50.53%
2022-06-30	-45.04%
2022-03-31	-80.29%
2021-12-31	-56.35%
2021-09-30	-56.62%
2021-06-30	-62.29%
2021-03-31	-91.78%
2020-12-31	-88.96%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-168.75%
2024-12-31	-169.98%
2023-12-31	-180.92%
2022-12-31	-47.41%
2021-12-31	-56.35%
2020-12-31	-88.96%
2019-12-31	-136.16%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20
Alkermes plc. (ALKS)		$6.844B	132.74
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07